Hyperdry human amniotic membrane application as a wound dressing for a full-thickness skin excision after a third-degree burn injury

Abstract

Background: Severe burn injuries create large skin defects that render the host susceptible to bacterial infections. Burn wound infection often causes systemic sepsis and severe septicemia, resulting in an increase in the mortality of patients with severe burn injuries. Therefore, appropriate wound care is important to prevent infection and improve patient outcomes. However, it is difficult to heal a third-degree burn injury. The aim of this study was to investigate whether hyperdry human amniotic membrane (HD-AM) could promote early granulation tissue formation after full-thickness skin excision in third-degree burn injury sites in mice. Methods: After the development of HD-AM and creation of a third-degree burn injury model, the HD-AM was either placed or not placed on the wound area in the HD-AM group or HD-AM group, respectively. The groups were prepared for evaluation on postoperative days 1, 4 and 7. Azan staining was used for granulation tissue evaluation, and estimation of CD163, transforming growth factor beta-1 (TGF-β1), vascular endothelial growth factor (VEGF), CD31, alpha-smooth muscle actin (α-SMA) and Iba1 expression was performed by immunohistochemical staining. Quantitative reverse-transcription polymerase chain reaction (PCR) was used to investigate gene expression of growth factors, cell migration chemokines and angiogenic and inflammatory markers. Results: The HD-AM group showed significant early and qualitatively good growth of granulation tissue on the full-thickness skin excision site. HD-AM promoted early-phase inflammatory cell infiltration, fibroblast migration and angiogenesis in the granulation tissue. Additionally, the early infiltration of cells of the immune system was observed. Conclusions: HD-AM may be useful as a new wound dressing material for full-thickness skin excision sites after third-degree burn injuries, and may be a new therapeutic technique for improving the survival rate of patients with severe burn injuries.

Keywords

Hyperdry human amniotic membrane / Third-degree burn / Granulation / Cell migration / Inflammation / Angiogenesis

References

[1] Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006; 19: 403-34.

[2] Weber J, McManus A. Nursing Committee of the International Society for burn injuries. Infection control in burn patients. Burns. 2004; 30: A16-24.

[3] Yoshino Y, Ohtsuka M, Kawaguchi M, Sakai K, Hashimoto A, Hayashi M, et al. The wound/burn guidelines-6: guidelines for the management of burns. J Dermatol. 2016; 43: 989-1010.

[4] Meshulam-Derazon S, Nachumovsky S, Ad-El D, Sulkes J, Hauben DJ, et al. Prediction of morbidity and mortality on admission to a burn unit. Plast Reconstr Surg. 2006; 118: 116-20.

[5] Brusselaers N, Pirayesh A, Hoeksema H, Richters CD, Verbelen J, Beele H, et al. Skin replacement in burn wounds. J Trauma. 2010; 68: 490-501.

[6] Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997; 38: 563-76 discussion 577.

[7] Zheng Y, Ji S, Wu H, Tian S, Zhang Y, Wang L, et al. Topical administration of cryopreserved living micronized amnion accelerates wound healing in diabetic mice by modulating local microenvironment. Biomaterials. 2017; 113: 56-67.

[8] Francisco JC, Correa Cunha R, Cardoso MA, Baggio Simeoni R, Mogharbel BF, Picharski GL, et al. Decellularized amniotic membrane scaffold as a pericardial substitute: an in vivo study. Transplant Proc. 2016; 48: 2845-9.

[9] Gholipourmalekabadi M, Bandehpour M, Mozafari M, Hashemi A, Ghanbarian H, Sameni M, et al. Decellularized human amniotic membrane: more is needed for an efficient dressing for protection of burns against antibiotic-resistant bacteria isolated from burn patients. Burns. 2015; 41: 1488-97.

[10] Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011; 108: 243-8.

[11] Tauzin H, Rolin G, Viennet C, Saas P, Humbert P, Muret P. A skin substitute based on human amniotic membrane. Cell Tissue Bank. 2014; 15: 257-65.

[12] Tehrani FA, Ahmadiani A, Niknejad H. The effects of preservation procedures on antibacterial property of amniotic membrane. Cryobiology. 2013; 67: 293-8.

[13] Koike C, Zhou K, Takeda Y, Fathy M, Okabe M, Yoshida T, et al. Characterization of amniotic stem cells. Cell Reprogram. 2014; 16: 298-305.

[14] Nagura S, Otaka S, Koike C, Okabe M, Yoshida T, Fathy M, et al. Effect of exogenous Oct4 overexpression on Cardiomyocyte differentiation of human amniotic Mesenchymal cells. Cell Reprogram. 2013; 15: 471-80.

[15] Otaka S, Nagura S, Koike C, Okabe M, Yoshida T, Fathy M, et al. Selective isolation of Nanog-positive human amniotic Mesenchymal cells and differentiation into Cardiomyocytes. Cell Reprogram. 2013; 15: 80-91.

[16] Fairbairn NG, Randolph MA, Redmond RW. The clinical applications of human amnion in plastic surgery. J Plast Reconstr Aesthet Surg. 2014; 67: 662-75.

[17] Okabe M, Kitagawa K, Yoshida T, Suzuki T, Waki H, Koike C, et al. Hyperdry human amniotic membrane is useful material for tissue engineering: physical, morphological properties, and safety as the new biological material. J Biomed Mater Res Part A. 2014; 102: 862-70.

[18] Okabe M, Kitagawa K, Yoshida T, Koike C, Katsumoto T, Fujihara E, et al. Application of 2-octyl-cyanoacrylate for corneal perforation and glaucoma filtering bleb leak. Clin Ophthalmol. 2013; 7: 649-53.

[19] Qi F, Yoshida T, Koike T, Aizawa H, Shimane T, Li Y, et al. Construction and characterization of human oral mucosa equivalent using hyper-dry amniotic membrane as a matrix. Arch Oral Biol. 2016; 65: 26-34.

[20] Tsuno H, Arai N, Sakai C, Okabe M, Koike C, Yoshida T, et al. Intraoral application of hyperdry amniotic membrane to surgically exposed bone surface. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117: e83-7.

[21] Okabe M, Yoshida T, Suzuki M, Goto M, Omori M, Taguchi M, et al. Hyperdry human amniotic membrane (HD-AM) is supporting Aciclovir included device of poly-N-p-vinylbenzyl-D-Lactonamide (PVLA) sphere for treatment of HSV-1 infected rabbit keratitis model. J Biotechnol Biomater. 2017. https://doi.org/10.4172/2155-952x.1000251.

[22] Saito A, Miyazaki H, Fujie T, Ohtsubo S, Kinoshita M, Saitoh D, et al. Therapeutic efficacy of an antibiotic-loaded nanosheet in a murine burn-wound infection model. J Biotechnol Biomater. 2012; 8: 2932-40.

[23] Li SW, Wang CY, Jou YJ, Yang TC, Huang SH, Wan L, et al. SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway. Sci Rep. 2016. https://doi.org/10.1038/srep25754.

[24] He C, Zhao C, Kumar A, Lee C, Chen M, Huang L, et al. Vasoprotective effect of PDGF-CC mediated by HMOX1 rescues retinal degeneration. Proc Natl Acad Sci U S A. 2014; 111: 14806-11.

[25] Veres-Székely A, Pap D, Sziksz E, Jávorszky E, Rokonay R, Lippai R, et al. Selective measurement of α smooth muscle actin: why β-actin can not be used as a housekeeping gene when tissue fibrosis occurs. BMC Mol Biol. 2017. https://doi.org/10.1186/s12867-017-0089-9.

[26] Johnston APW, Yuzwa SA, Carr MJ, Mahmud N, Storer MA, Krause MP, et al. Dedifferentiated Schwann cell precursors secreting paracrine factors are required for regeneration of the mammalian digit tip. Cell Stem Cell. 2016; 19: 433-48.

[27] Mishra PJ. Cell-free derivatives from mesenchymal stem cells are effective in wound therapy. World J Stem Cells. 2012; 4: 35.

[28] Charania MA, Ayyadurai S, Ingersoll SA, Xiao B, Viennois E, Yan Y, et al. Intestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis. Am J Physiol Gastrointest Liver Physiol. 2012; 302: G1282-91.

[29] Liu T, Shi Y, Du J, Ge X, Teng X, Liu L, et al. Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis. Sci Rep. 2016. https://doi.org/10.1038/srep32889.

[30] Magatti M, Vertua E, De Munari S, Caro M, Caruso M, Silini A, et al. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features. J Tissue Eng Regen Med. 2017; 11: 289-911.

[31] Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-6.

[32] Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol. 2000; 130: 641-9.

[33] DAVIS JW.Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910; 15: 307-96.

[34] Bujang-Safawi E, Halim AS, Khoo TL, Dorai AA. Dried irradiated human amniotic membrane as a biological dressing for facial burns-a 7-year case series. Burns. 2010; 36: 876-82.

[35] Rahman MS, Islam R, Rana MM, Spitzhorn LS, Rahman MS, Adjaye J, et al. Characterization of burn wound healing gel prepared from human amniotic membrane and Aloe vera extract. BMC Complement Altern Med. 2019; 19: 115.

[36] Joseph A, Dua HS, King AJ. Failure of amniotic membrane transplantation in the treatment of acute ocular burns. Br J Ophthalmol. 2001; 85: 1065-9.

[37] Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997; 77: 509-28.

[38] Martin P.Wound healing-aiming for perfect skin regeneration. Science. 1997; 276: 75-81.

[39] Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008; 453: 314-21.

[40] Perepelkin NMJ, Hayward K, Mokoena T, Bentley MJ, Ross-Rodriguez LU, Marquez-Curtis L, et al. Cryopreserved amniotic membrane as transplant allograft: viability and post-transplant outcome. Cell Tissue Bank. 2016; 17: 39-50.

[41] Lyons RM, Moses HL. Transforming Growth Factors and the Regulation of Cell Proliferation. Eur J Biochem 1990; 187: 467-73.

[42] Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994; 55: 97-179.

[43] Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol. 2004; 172: 7684-93.

[44] Hübner G, Brauchle M, Smola H, Madlener M, Fässler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine. 1996; 8: 548-56.

[45] Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005; 366: 1736-43.

[46] Quaglino D, Nanney LB, Ditesheim JA, Davidson JM. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Dermatol. 1991; 97: 34-42.

[47] Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994; 269: 6271-4.

[48] Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009; 58: 2574-82.

[49] Gilbert R, Vickaryous M, Viloria-Petit A. Signalling by transforming growth factor Beta isoforms in wound healing and tissue regeneration. J Dev Biol. 2016; 4: 21.

[50] Lu SW, Zhang XM, Luo HM, Fu YC, Xu MY, Tang SJ. Clodronate liposomes reduce excessive scar formation in a mouse model of burn injury by reducing collagen deposition and TGF-β1 expression. Mol Biol Rep. 2014; 41: 2143-9.

[51] Palumbo-Zerr K, Zerr P, Distler A, Fliehr J, Mancuso R, Huang J, et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis. Nat Med. 2015; 21: 150-8.

[52] Mohammadi A, Eskandari S, Johari H, Rajabnejad A. Using amniotic membrane as a novel method to reduce post-burn hypertrophic scar formation: a prospective follow-up study. J Cutan Aesthet Surg. 2017; 10: 13-7.

[53] Zhao B, Zhang Y, Han S, Zhang W, Zhou Q, Guan H, et al. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. J Mol Histol. 2017; 48: 121-32.

[54] Németh K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009; 15: 42-9.

[55] Leoni G, Neumann PA, Sumagin R, Denning TL, Nusrat A. Wound repair: role of immune-epithelial interactions. Mucosal Immunol. 2015; 8: 959-68.

[56] Shi J, Wu Z, Li Z, Ji J. Roles of macrophage subtypes in bowel anastomotic healing and anastomotic leakage. J Immunol Res. 2018; 2018: 1-8.

[57] Leydon C, Imaizumi M, Bartlett RS, Wang SF, Thibeault SL. Epithelial cells are active participants in vocal fold wound healing: an in vivo animal model of injury. PLoS One. 2014; 9. doi: 10.1371/journal.pone.0115389.

[58] Song M, Wang W, Ye Q, Bu S, Shen Z, Zhu Y. The repairing of full-thickness skin deficiency and its biological mechanism using decellularized human amniotic membrane as the wound dressing. Mater Sci Eng C Mater Biol Appl. 2017; 77: 739-47.

[59] Barski D, Gerullis H, Ecke T, Varga G, Boros M, Pintelon I, et al. Human amniotic membrane dressing for the treatment of an infected wound due to an entero-cutaneous fistula: case report. Int J Surg Case Rep. 2018; 51: 11-3.

[60] Zelen CM, Serena TE, Snyder RJ. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014; 11: 122-8.